ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, (2) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (3) ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens, being developed for multiple myeloma. Beyond these three product candidates, ORIC is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.
View Top Employees from ORIC Pharmaceuticals Inc.Website | https://oricpharma.com/ |
Ticker | PTLA |
Revenue | $26.3 million |
Funding | $173 million |
Employees | 109 (96 on RocketReach) |
Founded | 2014 |
Address | 240 E Grand Ave 2nd Floor, South San Francisco, California 94080, US |
Phone | (650) 388-5600 |
Fax | (650) 246-7376 |
Technologies |
JavaScript,
HTML,
PHP
+41 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Health Care, Healthcare, Pharmaceutical, Therapeutics |
Keywords | Cancer Drugs, Targeted Cancer Therapies, Oncology |
Competitors | Ascentage Pharma, G1 Therapeutics, Inc., Leap Therapeutics, Syndax Pharmaceuticals, TCR² Therapeutics Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular ORIC Pharmaceuticals Inc. employee's phone or email?
The ORIC Pharmaceuticals Inc. annual revenue was $26.3 million in 2024.
Dominic Piscitelli is the CFO of ORIC Pharmaceuticals Inc..
96 people are employed at ORIC Pharmaceuticals Inc..
ORIC Pharmaceuticals Inc. is based in South San Francisco, California.
The NAICS codes for ORIC Pharmaceuticals Inc. are [3254, 32, 32541, 325].
The SIC codes for ORIC Pharmaceuticals Inc. are [283, 28].